Back to Search Start Over

EROS is a selective chaperone regulating the phagocyte NADPH oxidase and purinergic signalling

Authors :
Lyra O Randzavola
Paige M Mortimer
Emma Garside
Elizabeth R Dufficy
Andrea Schejtman
Georgia Roumelioti
Lu Yu
Mercedes Pardo
Kerstin Spirohn
Charlotte Tolley
Cordelia Brandt
Katherine Harcourt
Esme Nichols
Mike Nahorski
Geoff Woods
James C Williamson
Shreehari Suresh
John M Sowerby
Misaki Matsumoto
Celio XC Santos
Cher Shen Kiar
Subhankar Mukhopadhyay
William M Rae
Gordon J Dougan
John Grainger
Paul J Lehner
Michael A Calderwood
Jyoti Choudhary
Simon Clare
Anneliese Speak
Giorgia Santilli
Alex Bateman
Kenneth GC Smith
Francesca Magnani
David C Thomas
Source :
eLife, Vol 11 (2022)
Publication Year :
2022
Publisher :
eLife Sciences Publications Ltd, 2022.

Abstract

EROS (essential for reactive oxygen species) protein is indispensable for expression of gp91phox, the catalytic core of the phagocyte NADPH oxidase. EROS deficiency in humans is a novel cause of the severe immunodeficiency, chronic granulomatous disease, but its mechanism of action was unknown until now. We elucidate the role of EROS, showing it acts at the earliest stages of gp91phox maturation. It binds the immature 58 kDa gp91phox directly, preventing gp91phox degradation and allowing glycosylation via the oligosaccharyltransferase machinery and the incorporation of the heme prosthetic groups essential for catalysis. EROS also regulates the purine receptors P2X7 and P2X1 through direct interactions, and P2X7 is almost absent in EROS-deficient mouse and human primary cells. Accordingly, lack of murine EROS results in markedly abnormal P2X7 signalling, inflammasome activation, and T cell responses. The loss of both ROS and P2X7 signalling leads to resistance to influenza infection in mice. Our work identifies EROS as a highly selective chaperone for key proteins in innate and adaptive immunity and a rheostat for immunity to infection. It has profound implications for our understanding of immune physiology, ROS dysregulation, and possibly gene therapy.

Details

Language :
English
ISSN :
2050084X
Volume :
11
Database :
Directory of Open Access Journals
Journal :
eLife
Publication Type :
Academic Journal
Accession number :
edsdoj.1b48b81ab31e44d4a2884318ac761009
Document Type :
article
Full Text :
https://doi.org/10.7554/eLife.76387